Paller, Amy S.
Gonzalez, Mercedes E.
Barnum, Sarah
Jaeger, Judith
Shao, Liyang
Ozturk, Zafer E.
Korotzer, Andrew
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals Inc.
Article History
Received: 11 June 2024
Revised: 11 June 2024
Accepted: 26 June 2024
First Online: 30 July 2024
Declarations
:
: This study was conducted in accordance with consensus ethical principles derived from international guidelines, including the Declaration of Helsinki, and consistent with the International Conference on Harmonisation Good Clinical Practice guideline and applicable regulatory requirements. Study registered in Protocol Registration and Results System (ClinicalTrials.gov) registration ID: NCT05203380.
: Written informed consent to participate in the trial and publication was obtained from all subjects’ legal guardians. Patients must also provide separate informed assent to enroll in the study, and sign and date either a separate informed assent form or the informed consent form signed by the parent/legal guardian.
: Amy S. Paller is an investigator for AbbVie, Dermavant, Eli Lilly, Incyte, Janssen, Krystal Biotech, LEO Pharma, and UCB; a consultant for Amryt Pharma, Azitra, BioCryst, BMS, Boehringer Ingelheim, Castle Creek Biosciences, Eli Lilly, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron Pharmaceuticals Inc., Sanofi, Seanergy, TWi Biotechnology, and UCB; and part of the data and safety monitoring boards for AbbVie, Abeona Therapeutics, Catawba Research, Galderma, and InMed Pharmaceuticals. Mercedes E. Gonzalez is an investigator for AbbVie, Amgen, Anterogen, Arcutis Biotherapeutics, Dermira, Dermavant, Eli Lilly, Incyte, Krystal Biotech, Regeneron Pharmaceuticals Inc., Sun Pharma, Verrica Pharmaceuticals; a speaker for Cerave, Dermavant, Galderma, Pfizer, Primus Pharmaceuticals, Regeneron Pharmaceuticals Inc., Sanofi, and Verrica Pharmaceuticals; and a consultant for Verrica Pharmaceuticals and Unilever. Sarah Barnum is an employee of CognitionMetrics, LLC, which has provided compensated consultative services to Ovid Therapeutics. Judith Jaeger is the President and owner of CognitionMetrics, LLC. CognitionMetrics, LLC has provided compensated consultative services to Ovid Therapeutics. Liyang Shao and Andrew Korotzer are employees and shareholders of Regeneron Pharmaceuticals Inc. Zafer E. Ozturk is an employee of and may hold stock and/or stock options in Sanofi.